Floatz logo

Flublok Quadrivalent

Acute Myocardial Infarction

Kaiser PermanentevaccineDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Acute Myocardial Infarction cohort.

Asset / SponsorPhaseRating
Sitagliptin
University of Sao Paulo General Hospital
Phase 3BB
Saxagliptin
University of Sao Paulo General Hospital
Phase 3BB
Asundexian
Bayer
Phase 1CC
Quadrivalent Inactivated Influenza Vaccine
Kaiser Permanente
D

Same molecule, other indications

Flublok Quadrivalent is also rated in:

influenzaDormant
D
Indicative ·
30 / 100
View asset →
pneumoniaDormant
D
Indicative ·
30 / 100
View asset →
respiratory tract infectious disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →